Answers are grounded in this paper and cite their sources.
PURPOSE: To determine the surgical outcome of mitomycin trabeculectomy in patients with refractory glaucoma. METHODS: Sixty-six eyes of 52 patients with refractory glaucoma underwent mitomycin trabeculectomy. Mitomycin was applied for five minutes only once during trabeculectomy. The follow-up period was six to 61 months. RESULTS: Cumulative success probability was calculated using Kaplan-Meier life-table analysis assuming the cut-off postoperative IOP to be 20 mmHg or IOP reduction by at least 20% in eyes with preoperative IOP 24 mmHg. At the end of 61-month follow-up the success probability was 80% +/- 6% without postoperative ocular hypotensive medication (complete success) and was 95% +/- 3% regardless of postoperative antiglaucoma medication (overall success), respectively. CONCLUSION: The data suggest that mitomycin trabeculectomy is efficacious in reducing IOP in patients with refractory glaucoma.
No takes yet. Share an insight, caveat, or question.
Kitazawa et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: